Veterinary News and Research

RSS

Scientists publish study results of AAV therapy product for treatment of RHO-adRP

Ophthotech Corporation announced today that scientists at the University of Pennsylvania and University of Florida published proof-of-concept study results on an adeno-associated virus gene therapy product candidate for the treatment of rhodopsin-mediated autosomal dominant retinitis pigmentosa licensed by Ophthotech.

22 Aug 2018

Study: Social disparities linked with higher prevalence of benign prostatic hyperplasia

In an Andrologia study of 100,000 men in Korea, social disparities--such as low education level and low household income, current or previous use of medical aid health insurance, blue-collar employment or unemployment, divorce, and low social capital of communities--were all linked with a higher prevalence of benign prostatic hyperplasia, a condition that is characterized by an enlarged prostate due to aging, lower urinary tract blockage, and other factors.

22 Aug 2018

New minimally invasive therapy shows promise for long-term reversal of Type 1 diabetes

What if instead of daily insulin injections or wearing pumps, just getting a shot every few months could reverse Type 1 diabetes for you - or your dog?

21 Aug 2018

Scientists report novel gene therapy that halts vision loss in canine model of blinding disease

Scientists funded by the National Eye Institute report a novel gene therapy that halts vision loss in a canine model of a blinding condition called autosomal dominant retinitis pigmentosa (adRP). The strategy could one day be used to slow or prevent vision loss in people with the disease. NEI is part of the National Institutes of Health.

21 Aug 2018

New drug- free, nanotechnology-based method detects and treats oral plaque

When the good and bad bacteria in our mouth become imbalanced, the bad bacteria form a biofilm (aka plaque), which can cause cavities, and if left untreated over time, can lead to cardiovascular and other inflammatory diseases like diabetes and bacterial pneumonia.

17 Aug 2018

FDA approves marketing of brainsway deep transcranial magnetic stimulation system for OCD

Today, the U.S. Food and Drug Administration permitted marketing of the Brainsway Deep Transcranial Magnetic Stimulation System for treatment of obsessive compulsive disorder (OCD).

17 Aug 2018

3D-printed human body parts to be used as teaching aids for surgical training

3D-printed human body parts with lifelike bone, skin and muscle densities are being developed in South Australia as teaching aids for surgical training.

17 Aug 2018

Eating white button mushrooms could improve regulation of glucose in the liver

Eating white button mushrooms can create subtle shifts in the microbial community in the gut, which could improve the regulation of glucose in the liver, according to a team of researchers.

16 Aug 2018

FDA grants approval for first generic version of epinephrine auto-injector

The U.S. Food and Drug Administration today approved the first generic version of EpiPen and EpiPen Jr (epinephrine) auto-injector for the emergency treatment of allergic reactions, including those that are life-threatening (anaphylaxis), in adults and pediatric patients who weigh more than 33 pounds.

16 Aug 2018

Study shows efficacy, safety of AAV5-based gene therapy to treat sheep model of achromatopsia

A study of a large animal model of achromatopsia caused by a mutation in the CNGA3 gene that was treated with a single injection of CNGA3 gene therapy delivered using an AAV5 vector revealed findings reported long-term follow-up findings that show promise for the efficacy and safety of this therapeutic approach.

15 Aug 2018

Researchers discover new approach to alleviate chronic itch

Two receptors in the spinal cord and the right experimental drug: Researchers at the University of Zurich have discovered a new approach that suppresses itch.

14 Aug 2018

Altered nitrogen metabolism may contribute to emergence of new cancer mutations

Nitrogen is a basic building block of all the body's proteins, RNA and DNA, so cancerous tumors are greedy for this element. Researchers at the Weizmann Institute of Science, in collaboration with colleagues from the National Cancer Institute and elsewhere, have now shown that in many cancers, the patient's nitrogen metabolism is altered, producing detectable changes in the body fluids and contributing to the emergence of new mutations in cancerous tissue.

13 Aug 2018

FDA permits marketing of first mobile medical app for contraceptive use to prevent pregnancy

The U.S. Food and Drug Administration today permitted marketing of the first mobile medical application (app) that can be used as a method of contraception to prevent pregnancy.

13 Aug 2018

FDA approves first oral medication for treatment of adults with Fabry disease

The U.S. Food and Drug Administration today approved Galafold (migalastat), the first oral medication for the treatment of adults with Fabry disease.

10 Aug 2018

FDA approves first vaginal ring contraceptive that can be used for one year

The U.S. Food and Drug Administration today approved Annovera (segesterone acetate and ethinyl estradiol vaginal system), which is a combined hormonal contraceptive for women of reproductive age used to prevent pregnancy and is the first vaginal ring contraceptive that can be used for an entire year.

10 Aug 2018

FDA approves first targeted RNA-based treatment for rare, fatal genetic disease

The U.S. Food and Drug Administration today approved Onpattro (patisiran) infusion for the treatment of peripheral nerve disease (polyneuropathy) caused by hereditary transthyretin-mediated amyloidosis (hATTR) in adult patients.

10 Aug 2018

FDA flags risks linked to improper use of ROM tests

The U.S. Food and Drug Administration today alerted women and their doctors about serious adverse events related to the improper use of tests intended as an aid in detecting if a pregnant woman's water has broken (also known as a rupture of the membranes containing amniotic fluid).

9 Aug 2018

FDA approves potassium chloride oral solution as first generic drug to receive CGT designation

The U.S. Food and Drug Administration today approved several strengths of potassium chloride oral solution as the first generic drugs to receive a Competitive Generic Therapy designation.

9 Aug 2018

FDA approves drug for rare, hard-to-treat types of non-Hodgkin lymphoma

The U.S. Food and Drug Administration today approved Poteligeo (mogamulizumab-kpkc) injection for intravenous use for the treatment of adult patients with relapsed or refractory mycosis fungoides or Sézary syndrome after at least one prior systemic therapy.

8 Aug 2018

FDA issues scientific recommendations to encourage development of novel drugs for treatment of OUD

The U.S. Food and Drug Administration today issued new scientific recommendations aimed at encouraging more widespread innovation and development of novel medication-assisted treatment drugs for the treatment of opioid use disorder.

7 Aug 2018

Veterinary News and Research

Scientists publish study results of AAV therapy product for treatment of RHO-adRP

Study: Social disparities linked with higher prevalence of benign prostatic hyperplasia

New minimally invasive therapy shows promise for long-term reversal of Type 1 diabetes

Scientists report novel gene therapy that halts vision loss in canine model of blinding disease

New drug- free, nanotechnology-based method detects and treats oral plaque

FDA approves marketing of brainsway deep transcranial magnetic stimulation system for OCD

3D-printed human body parts to be used as teaching aids for surgical training

Eating white button mushrooms could improve regulation of glucose in the liver

FDA grants approval for first generic version of epinephrine auto-injector

Study shows efficacy, safety of AAV5-based gene therapy to treat sheep model of achromatopsia

Researchers discover new approach to alleviate chronic itch

Altered nitrogen metabolism may contribute to emergence of new cancer mutations

FDA permits marketing of first mobile medical app for contraceptive use to prevent pregnancy

FDA approves first oral medication for treatment of adults with Fabry disease

FDA approves first vaginal ring contraceptive that can be used for one year

FDA approves first targeted RNA-based treatment for rare, fatal genetic disease

FDA flags risks linked to improper use of ROM tests

FDA approves potassium chloride oral solution as first generic drug to receive CGT designation

FDA approves drug for rare, hard-to-treat types of non-Hodgkin lymphoma

FDA issues scientific recommendations to encourage development of novel drugs for treatment of OUD

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News